医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Apira Science Inc. Expands iGrow Hair Growth System’s Global Footprint Across Asia and Middle East

2015年11月16日 PM10:00
このエントリーをはてなブックマークに追加


 

BOCA RATON, Fla.

Apira Science, Inc. today announced that it has received clearance to sell and distribute the iGrow Hair Growth System in South Korea, Thailand, Singapore, and Egypt. These latest clearances underscore Apira’s growing global reach, which stretches across five continents.

Clearances from the Korea Food and Drug Administration (KFDA), FDA Thailand, the Singapore Health Sciences Authority (HSA), and the Egyptian Ministry of Health (MoHP) bring iGrow’s patented low-level light therapy (LLLT) technology to these markets. These four countries add to the territories where iGrow is already approved, including the United States, all 28 European Union nations, Canada, Mexico, Hong Kong, India, Peru, and Turkey.

The iGrow Hair Growth System is an innovative, safe, and effective hands-free LLLT hair growth device cleared by the FDA for at-home use. In clinical studies, the iGrow’s patented red light technology, which consists of a highly productive combination of red laser and LED diodes, increased hair growth 37 percent after 16 weeks of therapy, and nearly doubled total hair growth 10 weeks faster than hand-held laser combs and brushes.

“Hair thinning and baldness extends across borders and continents with no regard for nationality, age, or gender,” said Jeff Braile, president of the Medical Products Division at Apira. “Adding certification in four new Asian and Middle Eastern countries brings a clinically proven LLLT treatment to those suffering from androgenetic alopecia and other causes of hair loss. And we are continuing our expansion, with clearances expected in a number of additional major markets prior to year-end.”

For more information on the iGrow Hair Growth System, visit www.igrowlaser.com.

About Apira Science, Inc.

Apira Science, Inc. has pioneered low-level light therapy (LLLT) for over a decade. Its iGrow Hair Growth Platform draws on its expertise and innovations in the application of LLLT to deliver a simple, safe, and effective hair growth treatment.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151116005094/en/

CONTACT

Gregory
FCA

Denise DiMeglio, 610-228-2102
denise@gregoryfca.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • CANbridge Life Sciences Receives Approval to Commence CAN017 Ib/III Trial in Esophageal Squamous Cell Cancer (ESCC) In China
  • AVEO Announces Acceptance of CANbridge Investigational New Drug Application for CAN017 (AV-203) Trial in Esophageal Squamous Cell Cancer (ESCC) in China
  • STAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic Cooperation Agreement
  • 新研究调查诊断性多通道睡眠检查之前采用Masimo SET®脉搏氧饱和度仪居家监测筛查唐氏综合征患儿罹患阻塞性睡眠呼吸暂停的风险
  • ダウン症候群の小児を対象とする睡眠時障害診断のマルチチャンネル研究に先立つ閉塞性睡眠時無呼吸症リスクのスクリーニングとしてMasimo SET®パルスオキシメトリーを使用するホームモニタリングの有用性を検討する新研究